Abstract: The invention relates to antibodies having specificity for human ROR1, compositions thereof, and methods for using such antibodies, including in the diagnosis and treatment of disorders associated with aberrant ROR1 expression.
Type:
Application
Filed:
November 30, 2011
Publication date:
September 26, 2013
Applicant:
The United States of America, as represented by the secretary, Department of Heath and Human Servi